Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Snapshot of some VERY long term Trogarzo users
View:
Post by qwerty22 on Feb 10, 2021 8:54am

Snapshot of some VERY long term Trogarzo users

The virological rationale for the drug is solid.

https://www.researchgate.net/publication/348173483_1027_Long-Term_Efficacy_Safety_and_Durability_of_Ibalizumab-Based_Regimens_in_Subgroup_of_TMB-202_Participants

"Conclusion : Data from 12 patients who received IBA for an average of 9 years validate the long-term efficacy and safety of IBA in TE patients. Importantly, for most patients, the durability of virologic response was maintained with minimal adjustments to the OBR. Altogether, these data demonstrate the contribution of IBA towards durable viral suppression in TE HIV patients with limited therapeutic options."
Comment by scarlet1967 on Feb 10, 2021 10:21am
Good find as per UK with a conservative administration I am not shocked also they are hit by covid19 badly so NHS is quite restrained at the moment, the company can now instead try to launch Trogarzo in other European Union countries.
Comment by scarlet1967 on Feb 10, 2021 12:11pm
It is all about$$$$. "Boris Johnson today froze ministerial pay in a stark signal on the need for public sector restraint amid the coronavirus meltdown. The PM acted amid growing outrage over plans to hand MPs a £3,000 hike because their salaries are linked to the wider public sector - which has been seeing a surge in pay over the past year. But fears are mounting about the ...more  
Comment by scarlet1967 on Feb 10, 2021 11:29am
This is the link to updated information re Trogarzo in EU. https://www.ema.europa.eu/en/documents/procedural-steps-after/trogarzo-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse